Prospective study to validate clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer

Prospective study to validate clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer

The clinical efficacy of DNA cytology test (CY) in gastric cancer (GC) has been retrospectively proposed utilizing cancer-specific methylation of the Cysteine dioxygenase sort 1 (CDO1). We confirmed its clinical utility of DNA CY in a potential cohort. Four hundred GC samples had been prospectively collected for laundry cytology (UMIN000026191), and detection of the DNA …

Prospective study to validate clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer Read More »